SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Statistical Analysis in Pharmacoeconomic Studies
16 references·0 citing·41 second hop
Statistical Analysis in Pharmacoeconomic Studies (1996)Statistical Analysis in Pharmacoeconomic …Valuing Health Care (1995)Valuing Health CareUncertainty in the economic evaluation of health care technologies: The role of sensitivity analysis (1994)Uncertainty in the economic e…Statistical analysis of cost outcomes in a randomized controlled clinical trial (1994)Statistical analysis of cost …In Search of Power and Significance: Issues in the Design and Analysis of Stochastic Cost-Effectiveness Studies in Health Care (1994)In Search of Power and Signif…Costs, effects and C/E‐ratios alongside a clinical trial (1994)Costs, effects and C/E‐ratios…Health Care CBA/CEA: An Update on the Growth and Composition of the Literature (1993)Health Care CBA/CEA: An Updat…Guidelines for Economic Analysis of Pharmaceutical Products (1993)Guidelines for Economic Analy…Cost-effectiveness of Monoclonal Antibodies to Gram-negative Endotoxin in the Treatment of Gram-negative Sepsis in ICU Patients (1993)Cost-effectiveness of Monoclo…How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. (1992)How attractive does a new tec…Guidelines for pharmacoeconomic studies. (1992)Guidelines for pharmacoeconom…Economic Analysis in Randomized Control Trials (1992)Economic Analysis in Randomiz…Cost-Effectiveness and Cost-Benefit Analyses in the Medical Literature (1992)Cost-Effectiveness and Cost-B…Counting the costs of chemotherapy in a National Cancer Institute of Canada randomized trial in nonsmall-cell lung cancer. (1990)Counting the costs of chemoth…The cost effectiveness of auranofin: results of a randomized clinical trial. (1988)The cost effectiveness of aur…Cost-effectiveness of cancer chemotherapy: an economic evaluation of a randomized trial in small-cell lung cancer. (1988)Cost-effectiveness of cancer …Probabilistic Sensitivity Analysis Using Monte Carlo Simulation (1985)Probabilistic Sensitivity Ana…Foundations of Cost-Effectiveness Analysis for Health and Medical Practices (1977)Prescribing selective serotonin reuptake inhibitors as strategy for prevention of suicide (1994)Cost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancer (1995)Economic evaluation of chemotherapy with mitoxantrone plus prednisone for symptomatic hormone-resistant prostate cancer: based on a Canadian randomized trial with palliative end points. (1998)Cost Accounting: A Managerial Emphasis, (2010)A methodological framework for assessing health indices (1985)Measurement of health state utilities for economic appraisal (1986)Meta-Analyses of Randomized Controlled Trials (1987)A study of the quality of life and cost-utility of renal transplantation (1996)Multiattribute Utility Function for a Comprehensive Health Status Classification System (1996)Handling uncertainty when performing economic evaluation of healthcare interventions. (1999)Thinking Outside the Box: Recent Advances in the Analysis and Presentation of Uncertainty in Cost-Effectiveness Studies (2002)Regression methods for covariate adjustment and subgroup analysis for non‐censored cost‐effectiveness data (2003)Clinical decision analysis (2005)Methods for the Economic Evaluation of Health Care Programmes (2005)Decision Analysis: Introductory Lectures on Choices Under Uncertainty. (1969)Judgment under Uncertainty: Heuristics and Biases (1974)Clinical Decision Analysis (1980)Handling Uncertainty in Cost-Effectiveness Models (2000)Review of guidelines for good practice in decision-analytic modelling in health technology assessment (2004)The Cost-Effectiveness of Lifestyle Modification or Metformin in Preventing Type 2 Diabetes in Adults with Impaired Glucose Tolerance (2005)A method for assessing the quality of a randomized control trial (1981)Assessing the costs of healthcare technologies in clinical trials. (1999)A Comprehensive League Table of Cost-Utility Ratios and a Sub-table of "Panel-worthy" Studies (2000)Growth and Quality of the Cost–Utility Literature, 1976–2001 (2005)Cost-Benefit Analysis (2020)Methods for the economic evaluation of health care programmes (1987)Generalisability in economic evaluation studies in healthcare: a review and case studies (2004)Interpreting the Results of Cost-Effectiveness Studies (2008)A Guide to Simulation (1983)Cost‐effectiveness acceptability curves – facts, fallacies and frequently asked questions (2004)Cost-Effectiveness Analysis Alongside Clinical Trials II—An ISPOR Good Research Practices Task Force Report (2015)A Clinician's Guide to Cost-Effectiveness Analysis (1990)Examining the Value and Quality of Health Economic Analyses: Implications of Utilizing the QHES (2003)Technology Assessment (2005)Alternative approaches to valuing intangible health losses: the evidence for multiple sclerosis (1998)Cost-Effectiveness Analyses of Vaccination Programmes (2008)Cost Effectiveness in Low- and Middle-Income Countries (2009)Pharmacoeconomic Analyses Using Discrete Event Simulation (2005)Risk of bias in model-based economic evaluations: the ECOBIAS checklist (2015)EQ-5D in Central and Eastern Europe: 2000–2015 (2016)
this work references cited by second hop

References

  • 1992How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations.1,581 cited
  • 1994Costs, effects and C/E‐ratios alongside a clinical trial963 cited
  • 1985Probabilistic Sensitivity Analysis Using Monte Carlo Simulation860 cited
  • 1994Uncertainty in the economic evaluation of health care technologies: The role of sensitivity analysis521 cited
  • 1992Cost-Effectiveness and Cost-Benefit Analyses in the Medical Literature410 cited
  • 1994In Search of Power and Significance: Issues in the Design and Analysis of Stochastic Cost-Effectiveness Studies in Health Care404 cited
  • 1992Guidelines for pharmacoeconomic studies.224 cited
  • 1995Valuing Health Care211 cited
  • 1990Counting the costs of chemotherapy in a National Cancer Institute of Canada randomized trial in nonsmall-cell lung cancer.205 cited
  • 1992Economic Analysis in Randomized Control Trials188 cited
  • 1993Health Care CBA/CEA: An Update on the Growth and Composition of the Literature165 cited
  • 1993Guidelines for Economic Analysis of Pharmaceutical Products142 cited
  • 1994Statistical analysis of cost outcomes in a randomized controlled clinical trial111 cited
  • 1993Cost-effectiveness of Monoclonal Antibodies to Gram-negative Endotoxin in the Treatment of Gram-negative Sepsis in ICU Patients

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

108 cited
  • 1988The cost effectiveness of auranofin: results of a randomized clinical trial.86 cited
  • 1988Cost-effectiveness of cancer chemotherapy: an economic evaluation of a randomized trial in small-cell lung cancer.84 cited
  • Cited by

    No citing works inside the corpus for this window.